Nexstim Plc (NXTMH.HE)
EUR 7.64
(9.46%)
EUR 7.64
(9.46%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 7.04 Million EUR | 14.66% |
| 2022 | 6.14 Million EUR | -10.11% |
| 2021 | 6.83 Million EUR | -11.21% |
| 2020 | 7.7 Million EUR | -8.27% |
| 2019 | 8.39 Million EUR | -15.68% |
| 2018 | 9.95 Million EUR | 80.27% |
| 2017 | 5.52 Million EUR | -7.0% |
| 2016 | 5.93 Million EUR | 4.9% |
| 2015 | 5.66 Million EUR | 4.76% |
| 2014 | 5.4 Million EUR | -0.47% |
| 2013 | 5.42 Million EUR | 48.42% |
| 2012 | 3.65 Million EUR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 9.32 Million EUR | 0.0% |
| 2023 Q1 | 5.42 Million EUR | -11.72% |
| 2023 Q3 | 7.04 Million EUR | 29.88% |
| 2023 Q4 | 7.04 Million EUR | -0.0% |
| 2023 FY | 7.04 Million EUR | 14.66% |
| 2023 Q2 | 5.42 Million EUR | 0.0% |
| 2022 Q2 | 5.91 Million EUR | 0.0% |
| 2022 Q4 | 6.14 Million EUR | 0.0% |
| 2022 Q1 | 5.91 Million EUR | -13.44% |
| 2022 FY | 6.14 Million EUR | -10.11% |
| 2022 Q3 | 6.14 Million EUR | 3.85% |
| 2021 Q1 | 6.91 Million EUR | -10.19% |
| 2021 Q2 | 6.91 Million EUR | -0.0% |
| 2021 Q3 | 6.83 Million EUR | -1.13% |
| 2021 Q4 | 6.83 Million EUR | 0.0% |
| 2021 FY | 6.83 Million EUR | -11.21% |
| 2020 Q4 | 7.7 Million EUR | 0.0% |
| 2020 FY | 7.7 Million EUR | -8.27% |
| 2020 Q3 | 7.7 Million EUR | 7.62% |
| 2020 Q2 | 7.15 Million EUR | 0.0% |
| 2020 Q1 | 7.15 Million EUR | -14.76% |
| 2019 FY | 8.39 Million EUR | -15.68% |
| 2019 Q1 | 9.33 Million EUR | -6.26% |
| 2019 Q2 | 9.33 Million EUR | 0.0% |
| 2019 Q3 | 8.39 Million EUR | -10.05% |
| 2019 Q4 | 8.39 Million EUR | 0.0% |
| 2018 Q3 | 9.95 Million EUR | 11.78% |
| 2018 FY | 9.95 Million EUR | 80.27% |
| 2018 Q1 | 8.9 Million EUR | 61.28% |
| 2018 Q4 | 9.95 Million EUR | 0.0% |
| 2018 Q2 | 8.9 Million EUR | 0.0% |
| 2017 Q1 | 4.33 Million EUR | -27.01% |
| 2017 Q3 | 5.52 Million EUR | 27.41% |
| 2017 FY | 5.52 Million EUR | -7.0% |
| 2017 Q4 | 5.52 Million EUR | 0.0% |
| 2017 Q2 | 4.33 Million EUR | 0.0% |
| 2016 Q1 | 4.88 Million EUR | -13.65% |
| 2016 Q3 | 5.93 Million EUR | 21.48% |
| 2016 FY | 5.93 Million EUR | 4.9% |
| 2016 Q2 | 4.88 Million EUR | 0.0% |
| 2016 Q4 | 5.93 Million EUR | 0.0% |
| 2015 FY | 5.66 Million EUR | 4.76% |
| 2015 Q3 | 5.66 Million EUR | 20.49% |
| 2015 Q4 | 5.66 Million EUR | 0.0% |
| 2015 Q2 | 4.69 Million EUR | 0.0% |
| 2015 Q1 | 4.69 Million EUR | -13.06% |
| 2014 FY | 5.4 Million EUR | -0.47% |
| 2014 Q4 | 5.4 Million EUR | 0.0% |
| 2014 Q3 | 5.4 Million EUR | -1.17% |
| 2014 Q2 | 5.46 Million EUR | -23.28% |
| 2014 Q1 | 7.12 Million EUR | 31.27% |
| 2013 Q2 | 1.35 Million EUR | 0.0% |
| 2013 Q4 | 5.42 Million EUR | 0.0% |
| 2013 FY | 5.42 Million EUR | 48.42% |
| 2013 Q3 | 5.42 Million EUR | 300.0% |
| 2013 Q1 | 1.35 Million EUR | 48.42% |
| 2012 Q3 | 914.53 Thousand EUR | 0.0% |
| 2012 Q4 | 914.53 Thousand EUR | 0.0% |
| 2012 Q1 | 914.53 Thousand EUR | 0.0% |
| 2012 FY | 3.65 Million EUR | 0.0% |
| 2012 Q2 | 914.53 Thousand EUR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| BBS-Bioactive Bone Substitutes Oyj | 5.5 Million EUR | -28.007% |
| Modulight Oyj | 8.23 Million EUR | 14.429% |
| Revenio Group Oyj | 37.6 Million EUR | 81.259% |